Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
35 studies found for:    " November 18, 2009":" December 18, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" November 18, 2009":" December 18, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Observational Study on Anti-Tat Immune Response in HIV-1-infected HAART-treated Adult Subjects
Condition: HIV Infection
Intervention:
2 Completed The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
Condition: HIV Infections
Intervention:
3 Completed Observational Study of the Therapeutic Study of Recombinant HIV-1 TAT
Condition: HIV Infection
Intervention:
4 Unknown  HIV Persistence and Viral Reservoirs
Conditions: HIV;   HIV Infections
Intervention: Drug: Raltegravir, tenofovir/emtricitabine
5 Completed Observational Study on Anti-Tat Immune Response in HIV-1-infected Asymptomatic Adult Subjects
Condition: HIV Infections
Intervention:
6 Completed Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test
Condition: HIV Infections
Intervention: Device: In Vitro Diagnostic Device
7 Terminated Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / Ritonavir
Condition: HIV Infections
Intervention: Drug: Kaletra
8 Completed TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278
Condition: HIV Infections
Intervention: Drug: TMC278 (Rilpivirine) LA; Placebo
9 Completed Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Condition: HIV Infections
Intervention:
10 Terminated Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV
Conditions: HIV Infections;   Hepatitis C Virus
Intervention:
11 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
12 Unknown  HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)
Condition: HIV Infections
Interventions: Drug: Pioglitazone;   Other: Observation
13 Completed
Has Results
Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults
Conditions: Tuberculosis;   HIV Infections
Interventions: Biological: AERAS-402;   Biological: Placebo
14 Completed Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers
Condition: Human Immunodeficiency Virus
Intervention: Drug: Raltegravir
15 Completed A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761 formulation 1;   Drug: GSK2248761 reference formulation;   Drug: GSK2248761 formulation 3;   Drug: GSK2248761 formulation 2 or 4
16 Completed
Has Results
Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons
Conditions: HSV Infection;   HIV Infection
Interventions: Drug: acyclovir;   Drug: valacyclovir
17 Completed S.T.A.R.S.: Sistas Talking About Real Solutions
Condition: HIV Prevention
Interventions: Behavioral: STARS: Sistas Talking About Real Solutions;   Behavioral: General Health & Nutrition
18 Completed Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)
Condition: HIV-1 Infections
Interventions: Drug: raltegravir; maraviroc; darunavir; ritonavir; tenofovir/emtricitabine;   Drug: darunavir; ritonavir; emtricitabine/tenofovir
19 Completed Pre-Exposure Prophylaxis in YMSM
Condition: HIV
Interventions: Drug: coformulated emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) as PrEP;   Drug: Placebo;   Behavioral: Many Men, Many Voices (3MV)
20 Completed Switching From Protease Inhibitor (PI) to Etravirine in HIV-1 Infected Subjects With Viremia Suppression
Condition: HIV
Interventions: Drug: Etravirine 400 mg dissolved in water every 24 hours;   Drug: Continue with the same antiretroviral regimen

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.